Holen Sie sich die Stockscreener-App
7.85
0.13%
-0.01
Handel nachbörslich:
7.86
0.01
+0.13%
Schlusskurs vom Vortag:
$7.86
Offen:
$8.5
24-Stunden-Volumen:
17.25M
Relative Volume:
1.58
Marktkapitalisierung:
$5.31B
Einnahmen:
$6.55B
Nettoeinkommen (Verlust:
$-530.20M
KGV:
-10.09
EPS:
-0.7777
Netto-Cashflow:
$495.00M
1W Leistung:
-5.19%
1M Leistung:
+5.94%
6M Leistung:
-32.21%
1J Leistung:
-38.14%
1-Tages-Spanne:
$7.475
$8.555
1-Wochen-Bereich:
$7.46
$8.555
52-Wochen-Spanne:
$7.265
$15.93
Avantor Inc Stock (AVTR) Company Profile
Firmenname
Avantor Inc
Sektor
Telefon
(610) 386-1700
Adresse
RADNOR CORPORATE CENTER, BUILDING ONE, RADNOR, PA
Compare AVTR vs ISRG, BDX, MDLN, ALC, RMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AVTR
Avantor Inc
|
7.85 | 5.31B | 6.55B | -530.20M | 495.00M | -0.7777 |
ISRG
Intuitive Surgical Inc
|
453.83 | 165.27B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
145.31 | 42.53B | 21.92B | 1.76B | 2.63B | 6.1223 |
MDLN
Medline Inc
|
43.40 | 37.41B | 28.43B | 1.16B | 1.26B | 1.4457 |
ALC
Alcon Inc
|
72.81 | 36.75B | 10.40B | 980.00M | 1.61B | 1.9749 |
RMD
Resmed Inc
|
211.93 | 31.63B | 5.40B | 1.49B | 1.78B | 10.12 |
Avantor Inc Stock (AVTR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-06 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2026-01-05 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2025-12-17 | Herabstufung | Jefferies | Hold → Underperform |
| 2025-12-15 | Herabstufung | BofA Securities | Buy → Neutral |
| 2025-11-04 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2025-10-30 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2025-10-30 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2025-08-01 | Herabstufung | Jefferies | Buy → Hold |
| 2025-04-29 | Herabstufung | Goldman | Buy → Neutral |
| 2025-04-28 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-04-28 | Herabstufung | Stifel | Buy → Hold |
| 2025-04-28 | Herabstufung | TD Cowen | Buy → Hold |
| 2025-01-17 | Herabstufung | UBS | Buy → Neutral |
| 2024-08-28 | Eingeleitet | Wells Fargo | Overweight |
| 2024-07-10 | Herabstufung | Citigroup | Buy → Neutral |
| 2024-01-04 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2023-12-11 | Hochstufung | TD Cowen | Market Perform → Outperform |
| 2023-09-28 | Eingeleitet | Bernstein | Mkt Perform |
| 2023-07-31 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2023-07-31 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2023-06-21 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-12-14 | Eingeleitet | Deutsche Bank | Hold |
| 2022-10-05 | Hochstufung | Citigroup | Neutral → Buy |
| 2022-09-14 | Herabstufung | Cowen | Outperform → Market Perform |
| 2022-09-09 | Herabstufung | Cleveland Research | Buy → Neutral |
| 2022-08-25 | Eingeleitet | Credit Suisse | Neutral |
| 2022-04-04 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-08-30 | Fortgesetzt | Raymond James | Outperform |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-08-02 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2021-06-04 | Eingeleitet | Goldman | Buy |
| 2021-04-29 | Hochstufung | Stifel | Hold → Buy |
| 2021-03-03 | Eingeleitet | Barclays | Overweight |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2020-09-14 | Eingeleitet | Morgan Stanley | Overweight |
| 2020-07-15 | Hochstufung | Cleveland Research | Neutral → Buy |
| 2020-01-08 | Eingeleitet | Wells Fargo | Overweight |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2019-11-15 | Eingeleitet | Stifel | Hold |
| 2019-08-02 | Eingeleitet | Cleveland Research | Neutral |
| 2019-06-14 | Eingeleitet | Janney | Buy |
| 2019-06-12 | Eingeleitet | Raymond James | Outperform |
| 2019-06-11 | Eingeleitet | Goldman | Buy |
| 2019-06-11 | Eingeleitet | Guggenheim | Buy |
| 2019-06-11 | Eingeleitet | JP Morgan | Overweight |
| 2019-06-11 | Eingeleitet | Jefferies | Buy |
| 2019-06-11 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2019-06-11 | Eingeleitet | Piper Jaffray | Neutral |
| 2019-06-11 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2019-06-11 | Eingeleitet | Robert W. Baird | Outperform |
| 2019-06-11 | Eingeleitet | SunTrust | Buy |
| 2019-06-11 | Eingeleitet | UBS | Buy |
| 2019-06-11 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Avantor Inc Aktie (AVTR) Neueste Nachrichten
Vanguard holds 35.8M shares of Avantor (AVTR) in Schedule 13G - Stock Titan
Avantor Reports "Turning Point" in Q1 2026 as Revival Transformation Begins to Deliver - Lab Manager
Avantor forecasts Q2 adjusted EPS of $0.19-$0.20 while incorporating $10M-$20M inflation headwind - MSN
Avantor, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
Avantor, Inc. Q1 2026 Financial Results, Risk Factors, and Forward-Looking Statements – SEC Form 10-Q Highlights - Minichart
Avantor Q1 2026 slides show turnaround progress, stock surges 10% - Investing.com
Avantor, Inc. (AVTR) Q1 earnings and revenues top estimates - MSN
Avantor shares jump 9% after Q1 earnings beat - MSN
Earnings call transcript: Avantor Q1 2026 beats expectations, stock surges - Investing.com
Avantor 10-Q: Revenue $1,581.4M, EPS $0.06 — Quarterly results - TradingView
Transcript: Avantor Q1 2026 Earnings Conference Call - Benzinga
[10-Q] Avantor, Inc. Quarterly Earnings Report - Stock Titan
Avantor, Inc. 2026 Q1ResultsEarnings Call Presentation (NYSE:AVTR) 2026-04-29 - Seeking Alpha
Avantor’s (NYSE:AVTR) Q1 CY2026 Sales Beat Estimates - StockStory
Avantor, Inc. (AVTR) Q1 Earnings and Revenues Top Estimates - Yahoo Finance
Avantor (AVTR) Surges After Smashing Q1 Estimates - ChartMill
Avantor stock surges 9% on first quarter earnings beat By Investing.com - Investing.com Australia
Avantor stock surges 9% on first quarter earnings beat - Investing.com
Earnings Flash (AVTR) Avantor, Inc. Reports Q1 Revenue $1.58B, vs. FactSet Est of $1.54B - marketscreener.com
Earnings Flash (AVTR) Avantor, Inc. Posts Q1 Adjusted EPS $0.17 per Share, vs. FactSet Est of $0.16 - marketscreener.com
Profits fall as Avantor (NYSE: AVTR) keeps 2026 outlook - Stock Titan
Avantor® Reports First Quarter 2026 Results - PR Newswire
Bronstein, Gewirtz & Grossman, LLC Encourages Avantor, Inc. (AVTR - The National Law Review
Avantor Q1 2026 earnings preview - MSN
Avantor earnings on deck as Revival turnaround faces test By Investing.com - Investing.com Nigeria
Avantor earnings on deck as Revival turnaround faces test - Investing.com
Avantor (AVTR) Q1 Earnings: What To Expect - Yahoo Finance
Avantor shares sink 14% after Q3 earnings miss and $785M impairment charge - MSN
Here's why you should hold Avantor stock in your portfolio for now - msn.com
Avantor rallies as Engine Capital takes 3% stake, pushes for strategy to double stock - msn.com
Avantor slips after adjusted profit miss - msn.com
Avantor, Inc. (AVTR) Stock Analysis: Evaluating The 33.89% Potential Upside - DirectorsTalk Interviews
Avantor Q4 2025 earnings preview - msn.com
Avantor shares drop more than 5% as turnaround efforts fail to excite investors - MSN
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Avantor, Inc. (AVTR) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Avantor stock up as new lab capabilities improve biopharma support - MSN
Avantor expands Masterflex portfolio to streamline bioprocessing - MSN
Avantor projects organic revenue growth of negative 2.5% to negative 0.5% for 2026 amid revival program and business resegmentation - MSN
Activist Investor to Push Avantor to Make Changes or Sell Itself - msn.com
Earnings Preview: Avantor to Report Financial Results Pre-market on April 29 - Moomoo
Avantor names Ludovic Brellier as EVP and transformation officer By Investing.com - Investing.com Australia
Avantor® Announces Ludovic Brellier as Executive Vice President, - GuruFocus
Avantor, Inc. Announces Executive Change and Files SEC Form 8-K – April 2026 - Minichart
Yacktman Fund's Avantor Inc(AVTR) Holding History - GuruFocus
Avantor Appoints New Executive VP and Transformation Leader - TipRanks
Avantor® announces Ludovic Brellier as executive vice president, bioscience & medtech products (BMP) & chief transformation officer - marketscreener.com
Avantor names Ludovic Brellier as EVP and transformation officer - Investing.com
Avantor (NYSE: AVTR) taps Ludovic Brellier to lead BMP and transformation - Stock Titan
Avantor® Announces Ludovic Brellier as Executive Vice President, Bioscience & Medtech Products (BMP) & Chief Transformation Officer - Nasdaq
Avantor, Inc. (AVTR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Stanley Capital Management, LLC's Avantor Inc(AVTR) Holding History - GuruFocus
Finanzdaten der Avantor Inc-Aktie (AVTR)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.80%
0.63%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):